Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a

Waters Corporation (WAT) Free cash flow

Alert me on Free cash flow

Waters Corporation's free cash flow for fiscal 2025 was $507.6M, down 18.1% from $619.6M in fiscal 2024. Over the twelve months to 30 June 2026 it was $366.6M. Over the past ten years it has ranged from −$840.2M (fiscal 2023) to $619.6M (fiscal 2024); the current reading is higher than 45% of that period. Waters Corporation ranks 15th of 52 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $507.6M (18.08%)
FY2024 $619.6M —
FY2023 −$840.2M —
FY2022 $428.2M (26.05%)
FY2021 $579.0M 7.71%
FY2020 $537.6M 12.17%
FY2019 $479.3M (5.72%)
FY2018 $508.4M (16.27%)
FY2017 $607.2M 10.00%
FY2016 $552.0M 16.11%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $153.0M —
Mar 2026 −$42.0M —
Dec 2025 $93.4M (42.45%)
Sep 2025 $162.2M 801.28%
42 more quarters

Against its own ten years

Low −$840.2M High $619.6M
Ten-year median $508.4M
Current reading's percentile 45

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on WAT